PAM
IRWD icon

Panagora Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Panagora Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-54,408
Closed -$183K – 1216
2025
Q4 		$183K Sell
54,408
-104,554
-66% -$272K ﹤0.01% 1139
2025
Q3 		$208K Buy
158,962
+112,393
+241% +$116K ﹤0.01% 1083
2025
Q2 		$33.4K Hold
46,569
– – ﹤0.01% 1108
2025
Q1 		$68.5K Sell
46,569
-1,797
-4% -$4.28K ﹤0.01% 1088
2024
Q4 		$214K Buy
48,366
+33
+0.1% +$134 ﹤0.01% 1054
2024
Q3 		$199K Buy
+48,333
New +$260K ﹤0.01% 1147
2023
Q2 		– Sell
-38,332
Closed -$403K – 1370
2023
Q1 		$403K Hold
38,332
– – ﹤0.01% 1177
2022
Q4 		$475K Sell
38,332
-9,186
-19% -$104K ﹤0.01% 1172
2022
Q3 		$492K Hold
47,518
– – ﹤0.01% 1143
2022
Q2 		$548K Buy
+47,518
New +$560K ﹤0.01% 1129
2022
Q1 		– Sell
-26,528
Closed -$309K – 1557
2021
Q4 		$309K Sell
26,528
-62,025
-70% -$761K ﹤0.01% 1365
2021
Q3 		$1.16M Sell
88,553
-3,898
-4% -$50.4K 0.01% 897
2021
Q2 		$1.19M Buy
+92,451
New +$1.06M 0.01% 911
2020
Q3 		– Sell
-156,339
Closed -$1.61M – 2722
2020
Q2 		$1.61M Sell
156,339
-218
-0.1% -$2.23K 0.01% 746
2020
Q1 		$1.58M Sell
156,557
-447,949
-74% -$5.27M 0.01% 681
2019
Q4 		$8.05M Buy
604,506
+202,955
+51% +$2.24M 0.04% 374
2019
Q3 		$3.45M Buy
401,551
+9,117
+2% +$88.6K 0.02% 567
2019
Q2 		$4.29M Buy
392,434
+87,225
+29% +$977K 0.02% 539
2019
Q1 		$3.46M Buy
305,209
+259,307
+565% +$2.9M 0.02% 632
2018
Q4 		$398K Buy
+45,902
New +$527K ﹤0.01% 1393
2016
Q1 		– Sell
-829
Closed -$8K – 2315
2015
Q4 		$8K Sell
829
-850
-51% -$8.21K ﹤0.01% 2226
2015
Q3 		$15K Buy
+1,679
New +$15.7K ﹤0.01% 2179

Other funds holding IRWD

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Panagora Asset Management's IRWD Position: Q1 2026 in Review

Panagora Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2026, closing a stake of 54,408 shares — an estimated $183K sold.

Panagora Asset Management first reported a position in IRWD in Q3 2015 and held it in 22 quarters. The position peaked at $8.05M in Q4 2019. 227 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Panagora Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Panagora Asset Management sold 54,408 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $183K.
  • Panagora Asset Management first reported a position in Ironwood Pharmaceuticals in Q3 2015 and held it in 22 quarters.
  • Panagora Asset Management's Ironwood Pharmaceuticals position peaked at $8.05M in Q4 2019.
  • 227 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.